1. Home
  2. NBIX vs PNW Comparison

NBIX vs PNW Comparison

Compare NBIX & PNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$149.94

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Pinnacle West Capital Corporation

PNW

Pinnacle West Capital Corporation

HOLD

Current Price

$99.40

Market Cap

11.1B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
PNW
Founded
1992
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
11.1B
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
NBIX
PNW
Price
$149.94
$99.40
Analyst Decision
Strong Buy
Hold
Analyst Count
22
15
Target Price
$180.91
$100.21
AVG Volume (30 Days)
1.1M
820.7K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
3.58%
EPS Growth
41.95
N/A
EPS
1.91
0.27
Revenue
$161,626,000.00
$5,339,939,000.00
Revenue This Year
$24.73
$5.15
Revenue Next Year
$13.14
$6.89
P/E Ratio
$77.03
$372.07
Revenue Growth
977.51
4.20
52 Week Low
$115.66
$85.32
52 Week High
$160.18
$104.92

Technical Indicators

Market Signals
Indicator
NBIX
PNW
Relative Strength Index (RSI) 76.44 40.67
Support Level $133.96 $86.28
Resistance Level $158.92 $104.22
Average True Range (ATR) 3.63 1.86
MACD 2.00 -0.45
Stochastic Oscillator 98.20 5.57

Price Performance

Historical Comparison
NBIX
PNW

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About PNW Pinnacle West Capital Corporation

Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases 6.5 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.

Share on Social Networks: